Marianne Wallenius
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Marianne Wallenius has a total of 43 co-authors. Here are the top co-authors by number of shared publications:
Johan F. Skomsvoll
Department of Rheumatology, National Advisory Unit on Pregnancy and Rheumatic Diseases, Trondheim University Hospital, Trondheim, Norway
8 shared publicationsKjell Å. Salvesen
Department of Obstetrics and Gynecology, National Center for Fetal Medicine, Trondheim University Hospital, Trondheim, Norway
8 shared publicationsAnne K. Daltveit
Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway
6 shared publicationsC Kaufmann
Buskerud Central Hospital, Drammen, Norway
3 shared publicationsK Mikkelsen
Lillehammer Hospital for Rheumatic Diseases, Lillehammer, Norway
3 shared publicationsKnut Mikkelsen
Lillehammer Hospital for Rheumatic Diseases Lillehammer Norway
3 shared publications
Latest Publications
- Open Access
- 1 August 2023
- Published by Springer Nature in International Breastfeeding Journal
- Vol. 18 (1) , 1-9
Breastfeeding in women with systemic lupus erythematosus: results from a Norwegian quality register
Background: Knowledge on breastfeeding among women with systemic lupus erythematosus (SLE) is sparse. We wanted to identify the frequency of breastfeeding in SLE, and to compare breastfeeding women with SLE to non-breastfeeding women to examine possible differences in disease characteristics and self-reported health data between the groups. Methods: Prospective data on women with SLE from RevNatus, a consent-based Norwegian nationwide quality register was used for this study. Data were collected during January 2016 to September 2021. We used data registered at inclusion when planning pregnancy or in 1st trimester, and 6 weeks, 6 and 12 months after delivery. Breastfeeding and non-breastfeeding patients were compared according to demographic, serological and obstetric data as well as disease activity, medication, self-reported pain, and fatigue. Results: A total of 114 pregnancies in 101 SLE women were included in the analysis. A majority of the women (78%) breastfed six weeks postpartum. Six and 12 months after delivery, breastfeeding rates were 54% and 30% respectively. Six weeks postpartum, non-breastfeeding women showed higher prevalence of emergency caesarean delivery (p = 0.038), preeclampsia (p = 0.056) and lower educational level (p = 0.046) compared to breastfeeding women. 12 months after delivery, we observed a higher frequency of multiparity among breastfeeding women (p = 0.017) compared to non-breastfeeding. Overall, we found low disease activity in both groups at all registrations in the follow-up, and disease activity did not differ between the groups. More than 70% of both breastfeeding and non-breastfeeding women used hydroxychloroquine (HCQ). Conclusions: Breastfeeding rate in women with SLE was high six weeks postpartum. Multiparous women breastfed longer than primiparas. Disease activity, use of HCQ, and self-reported health data were comparable between the groups. Our data indicate that health professionals should encourage women with SLE to breastfeed.
- 1 August 2023
- Published by Springer Nature in International Breastfeeding Journal
- Vol. 18 (1) , 1-9
Open AccessBreastfeeding in women with systemic lupus erythematosus: results from a Norwegian quality register
Background: Knowledge on breastfeeding among women with systemic lupus erythematosus (SLE) is sparse. We wanted to identify the frequency of breastfeeding in SLE, and to compare breastfeeding women with SLE to non-breastfeeding women to examine possible differences in disease characteristics and self-reported health data between the groups. Methods: Prospective data on women with SLE from RevNatus, a consent-based Norwegian nationwide quality register was used for this study. Data were collected during January 2016 to September 2021. We used data registered at inclusion when planning pregnancy or in 1st trimester, and 6 weeks, 6 and 12 months after delivery. Breastfeeding and non-breastfeeding patients were compared according to demographic, serological and obstetric data as well as disease activity, medication, self-reported pain, and fatigue. Results: A total of 114 pregnancies in 101 SLE women were included in the analysis. A majority of the women (78%) breastfed six weeks postpartum. Six and 12 months after delivery, breastfeeding rates were 54% and 30% respectively. Six weeks postpartum, non-breastfeeding women showed higher prevalence of emergency caesarean delivery (p = 0.038), preeclampsia (p = 0.056) and lower educational level (p = 0.046) compared to breastfeeding women. 12 months after delivery, we observed a higher frequency of multiparity among breastfeeding women (p = 0.017) compared to non-breastfeeding. Overall, we found low disease activity in both groups at all registrations in the follow-up, and disease activity did not differ between the groups. More than 70% of both breastfeeding and non-breastfeeding women used hydroxychloroquine (HCQ). Conclusions: Breastfeeding rate in women with SLE was high six weeks postpartum. Multiparous women breastfed longer than primiparas. Disease activity, use of HCQ, and self-reported health data were comparable between the groups. Our data indicate that health professionals should encourage women with SLE to breastfeed.
- Open Access
- 31 May 2016
- Published by Springer Nature in BMC Pregnancy and Childbirth
- Vol. 16 (1) , 123
Reproductive trends in females with inflammatory joint disease
The study assessed birth trends per decade in offspring of females with inflammatory joint diseases (IJD) compared with women without IJD. This retrospective cohort study is based on data from the Medical Birth Registry of Norway from 1967 to 2009. We investigated singleton births in females with IJD (n = 7502) and compared with births from the general population (n = 2 437 110). Four periods were examined: 1967–79, 1980–89, 1990–99 and 2000–09. In the logistic regression analysis adjustments were made for maternal age at delivery and birth order. Odds ratios were obtained for the associations between IJD and birth outcome for each period. Females with IJD had in average 65 deliveries / year (0.08 % of all births) in the 1970ies and 274 deliveries / year (0.5 % of all births) from 2000 to 2009. Adjusted Odds ratios (aOR) for newborns small for gestational age were 1.5 (95 % CI 1.2, 1.9) in the earliest and 1.1 (95 % CI 0.9, 1.2) in the last period. Correspondingly, for birth weight < 2500 grams aOR decreased from 1.4 (95 % CI 1.0, 1.9) to 1.1 (95 % CI 0.9, 1.4). For preterm birth aOR was 1.1 (95 % CI 0.8, 1.5) in the first and 1.3 (95 % CI (1.1, 1.5) in the last period. An increasing number of births among females with IJD were observed in the study period. Birth weights of newborns of IJD women approached to birth weights in the general population, but preterm birth remained a problem.
- 31 May 2016
- Published by Springer Nature in BMC Pregnancy and Childbirth
- Vol. 16 (1) , 123
Open AccessReproductive trends in females with inflammatory joint disease
The study assessed birth trends per decade in offspring of females with inflammatory joint diseases (IJD) compared with women without IJD. This retrospective cohort study is based on data from the Medical Birth Registry of Norway from 1967 to 2009. We investigated singleton births in females with IJD (n = 7502) and compared with births from the general population (n = 2 437 110). Four periods were examined: 1967–79, 1980–89, 1990–99 and 2000–09. In the logistic regression analysis adjustments were made for maternal age at delivery and birth order. Odds ratios were obtained for the associations between IJD and birth outcome for each period. Females with IJD had in average 65 deliveries / year (0.08 % of all births) in the 1970ies and 274 deliveries / year (0.5 % of all births) from 2000 to 2009. Adjusted Odds ratios (aOR) for newborns small for gestational age were 1.5 (95 % CI 1.2, 1.9) in the earliest and 1.1 (95 % CI 0.9, 1.2) in the last period. Correspondingly, for birth weight < 2500 grams aOR decreased from 1.4 (95 % CI 1.0, 1.9) to 1.1 (95 % CI 0.9, 1.4). For preterm birth aOR was 1.1 (95 % CI 0.8, 1.5) in the first and 1.3 (95 % CI (1.1, 1.5) in the last period. An increasing number of births among females with IJD were observed in the study period. Birth weights of newborns of IJD women approached to birth weights in the general population, but preterm birth remained a problem.
- 16 September 2015
- Published by Wiley in Acta Obstetricia et Gynecologica Scandinavica
- Vol. 94 (11) , 1195-1202
Secular trends of pregnancies in women with inflammatory connective tissue disease
This study examined secular trends in reproductive outcome in women with inflammatory connective tissue disease compared with reference deliveries from the general population. Historical cohort study based on data registered in the Medical Birth Register of Norway from 1967 to 2009. The study included singleton births in women recorded with connective tissue disease (n = 851) and reference deliveries from the general population (n = 2 437 110). Births were stratified in four periods, 1967-1979, 1980-1989, 1990-1999 and 2000-2009. Associations between connective tissue disease and maternal and perinatal outcomes by decade were assessed in logistic regression analyses and adjusted for maternal age at delivery and parity. In the 1970s, around 2.7 deliveries/year were registered for women with connective tissue disease (0.004% of all deliveries). This increased to 42 deliveries/year (0.07% of all deliveries) after 2000. Adjusted odds ratios (aOR) for cesarean section were 5.0 (95% CI 2.1-11.9) in the first and 1.8 (95% CI 1.4-2.3) in the last period. For preterm delivery the aOR decreased from 4.9 (95% CI 2.1-11.4) to 3.1 (95% CI 2.3-4.2) and the aOR for birthweight <2500 g changed from 7.3 (95% CI 3.3-16.3) to 4.1 (95% CI 3.0-5.6). An increasing number of births were observed over time among women with connective tissue disease. Adverse pregnancy outcomes were more common among women with connective tissue disease but risks have decreased over time.
- 16 September 2015
- Published by Wiley in Acta Obstetricia et Gynecologica Scandinavica
- Vol. 94 (11) , 1195-1202
Secular trends of pregnancies in women with inflammatory connective tissue disease
This study examined secular trends in reproductive outcome in women with inflammatory connective tissue disease compared with reference deliveries from the general population. Historical cohort study based on data registered in the Medical Birth Register of Norway from 1967 to 2009. The study included singleton births in women recorded with connective tissue disease (n = 851) and reference deliveries from the general population (n = 2 437 110). Births were stratified in four periods, 1967-1979, 1980-1989, 1990-1999 and 2000-2009. Associations between connective tissue disease and maternal and perinatal outcomes by decade were assessed in logistic regression analyses and adjusted for maternal age at delivery and parity. In the 1970s, around 2.7 deliveries/year were registered for women with connective tissue disease (0.004% of all deliveries). This increased to 42 deliveries/year (0.07% of all deliveries) after 2000. Adjusted odds ratios (aOR) for cesarean section were 5.0 (95% CI 2.1-11.9) in the first and 1.8 (95% CI 1.4-2.3) in the last period. For preterm delivery the aOR decreased from 4.9 (95% CI 2.1-11.4) to 3.1 (95% CI 2.3-4.2) and the aOR for birthweight <2500 g changed from 7.3 (95% CI 3.3-16.3) to 4.1 (95% CI 3.0-5.6). An increasing number of births were observed over time among women with connective tissue disease. Adverse pregnancy outcomes were more common among women with connective tissue disease but risks have decreased over time.
- 15 July 2015
- Published by The Journal of Rheumatology in The Journal of Rheumatology
- Vol. 42 (9) , 1570-1572
Miscarriage and Stillbirth in Women with Rheumatoid Arthritis
Objective To examine the risk of pregnancy loss in women with rheumatoid arthritis (RA). Methods Cumulative numbers of early miscarriages (before gestational Week 12), late miscarriages (weeks 12–22), and stillbirths reported to the Medical Birth Registry of Norway in the period 1999–2009. Results There were 1578 women with RA and 411,130 reference women included in the study. Relative risks of early and late miscarriage in women with RA versus references were 1.2 (95% CI 1.1–1.3) and 1.4 (95% CI 1.1–1.7), respectively. There was no difference in stillbirth. Conclusion The risk of miscarriage was slightly higher among women with RA than in references.
- 15 July 2015
- Published by The Journal of Rheumatology in The Journal of Rheumatology
- Vol. 42 (9) , 1570-1572
Miscarriage and Stillbirth in Women with Rheumatoid Arthritis
Objective To examine the risk of pregnancy loss in women with rheumatoid arthritis (RA). Methods Cumulative numbers of early miscarriages (before gestational Week 12), late miscarriages (weeks 12–22), and stillbirths reported to the Medical Birth Registry of Norway in the period 1999–2009. Results There were 1578 women with RA and 411,130 reference women included in the study. Relative risks of early and late miscarriage in women with RA versus references were 1.2 (95% CI 1.1–1.3) and 1.4 (95% CI 1.1–1.7), respectively. There was no difference in stillbirth. Conclusion The risk of miscarriage was slightly higher among women with RA than in references.
- 27 December 2014
- Published by Wiley in Arthritis & Rheumatology
- Vol. 67 (1) , 296-301
Brief Report: No Excess Risks in Offspring With Paternal Preconception Exposure to Disease‐Modifying Antirheumatic Drugs
Objective: To examine pregnancy outcomes in the partners of male patients with inflammatory joint disease who were or were not exposed to disease‐modifying antirheumatic drugs (DMARDs) before conception compared with the outcomes in reference subjects from the general population.Methods: Linkage of data from a longitudinal observational study of patients with inflammatory joint disease (the Norwegian Disease‐Modifying Antirheumatic Drug [NOR‐DMARD] registry study) and the Medical Birth Registry of Norway (MBRN) enabled a comparison of pregnancy outcomes in the partners of men with inflammatory joint disease. Outcomes of pregnancies in which the father was exposed to DMARDs within 12 weeks of conception and those in which the father was never exposed to DMARDs were analyzed separately and compared with the outcomes in reference subjects. Potential associations between DMARD exposure and adverse pregnancy outcomes were assessed by logistic regression analysis.Results: A total of 1,796 men with inflammatory joint disease were associated with 2,777 births in the MBRN. In 110 of these births, the father had been exposed to DMARDs within 12 weeks before conception, and in 230 births the father had never been exposed to DMARDs before conception. The DMARDs (monotherapy or combination treatment) to which the fathers were exposed most frequently within 12 weeks of conception were methotrexate (n = 49), sulfasalazine (n = 17), and tumor necrosis factor inhibitors (n = 57). Neither adverse pregnancy outcomes nor occurrence of congenital malformations differed between patients and reference subjects in either group.Conclusion: Preconception paternal exposure to DMARDs was not associated with an increase in adverse pregnancy outcomes. Importantly, no increased risk of congenital malformations was observed.
- 27 December 2014
- Published by Wiley in Arthritis & Rheumatology
- Vol. 67 (1) , 296-301
Brief Report: No Excess Risks in Offspring With Paternal Preconception Exposure to Disease‐Modifying Antirheumatic Drugs
Objective: To examine pregnancy outcomes in the partners of male patients with inflammatory joint disease who were or were not exposed to disease‐modifying antirheumatic drugs (DMARDs) before conception compared with the outcomes in reference subjects from the general population.Methods: Linkage of data from a longitudinal observational study of patients with inflammatory joint disease (the Norwegian Disease‐Modifying Antirheumatic Drug [NOR‐DMARD] registry study) and the Medical Birth Registry of Norway (MBRN) enabled a comparison of pregnancy outcomes in the partners of men with inflammatory joint disease. Outcomes of pregnancies in which the father was exposed to DMARDs within 12 weeks of conception and those in which the father was never exposed to DMARDs were analyzed separately and compared with the outcomes in reference subjects. Potential associations between DMARD exposure and adverse pregnancy outcomes were assessed by logistic regression analysis.Results: A total of 1,796 men with inflammatory joint disease were associated with 2,777 births in the MBRN. In 110 of these births, the father had been exposed to DMARDs within 12 weeks before conception, and in 230 births the father had never been exposed to DMARDs before conception. The DMARDs (monotherapy or combination treatment) to which the fathers were exposed most frequently within 12 weeks of conception were methotrexate (n = 49), sulfasalazine (n = 17), and tumor necrosis factor inhibitors (n = 57). Neither adverse pregnancy outcomes nor occurrence of congenital malformations differed between patients and reference subjects in either group.Conclusion: Preconception paternal exposure to DMARDs was not associated with an increase in adverse pregnancy outcomes. Importantly, no increased risk of congenital malformations was observed.
- 24 October 2014
- Published by Wiley in Arthritis Care & Research
- Vol. 66 (11) , 1718-1724
Systemic Lupus Erythematosus and Outcomes in First and Subsequent Births Based on Data From a National Birth Registry
Objective: To examine the associations between systemic lupus erythematosus (SLE) and outcomes in first and subsequent births.Methods: Data from the Medical Birth Registry of Norway during the period December 1, 1998 to December 31, 2009 were used to assess maternal and perinatal outcomes in women diagnosed with SLE compared with the general population. Outcomes of first and subsequent births were analyzed separately. Associations between SLE and pregnancy outcomes were assessed in logistic regression analyses and are shown as adjusted odds ratios (aORs) after adjustment for maternal age, gestational age, smoking habits, and previous cesarean section (CS), when relevant.Results: We analyzed 95 first and 145 subsequent births in patients and compared them with references. The risk of CS was two‐fold higher in SLE patients in first and subsequent births. More newborns of patients had a birth weight <2,500 gm (aOR 5.00 [95 % confidence interval (95% CI) 3.02, 8.27] in first births and aOR 4.33 [95% CI 2.64, 7.10] in subsequent births). Additionally, preterm birth was more frequent among SLE patients (aOR 4.04 [95% CI 2.45, 6.56] in first births and aOR 3.13 [95% CI 1.97, 4.98] in subsequent births). Congenital malformations were more prevalent among children of patients than references (aOR 2.71 [95% CI 1.25, 5.86] in first births and aOR 3.13 [95% CI 1.69, 5.79] in subsequent births). Perinatal death was more frequent in first births among patients (aOR 7.34 [95% CI 2.69, 20.03]), but no difference was observed in subsequent births.Conclusion: Pregnancy complications were more frequent in SLE patients than references, and the greatest differences between groups were observed in first births.
- 24 October 2014
- Published by Wiley in Arthritis Care & Research
- Vol. 66 (11) , 1718-1724
Systemic Lupus Erythematosus and Outcomes in First and Subsequent Births Based on Data From a National Birth Registry
Objective: To examine the associations between systemic lupus erythematosus (SLE) and outcomes in first and subsequent births.Methods: Data from the Medical Birth Registry of Norway during the period December 1, 1998 to December 31, 2009 were used to assess maternal and perinatal outcomes in women diagnosed with SLE compared with the general population. Outcomes of first and subsequent births were analyzed separately. Associations between SLE and pregnancy outcomes were assessed in logistic regression analyses and are shown as adjusted odds ratios (aORs) after adjustment for maternal age, gestational age, smoking habits, and previous cesarean section (CS), when relevant.Results: We analyzed 95 first and 145 subsequent births in patients and compared them with references. The risk of CS was two‐fold higher in SLE patients in first and subsequent births. More newborns of patients had a birth weight <2,500 gm (aOR 5.00 [95 % confidence interval (95% CI) 3.02, 8.27] in first births and aOR 4.33 [95% CI 2.64, 7.10] in subsequent births). Additionally, preterm birth was more frequent among SLE patients (aOR 4.04 [95% CI 2.45, 6.56] in first births and aOR 3.13 [95% CI 1.97, 4.98] in subsequent births). Congenital malformations were more prevalent among children of patients than references (aOR 2.71 [95% CI 1.25, 5.86] in first births and aOR 3.13 [95% CI 1.69, 5.79] in subsequent births). Perinatal death was more frequent in first births among patients (aOR 7.34 [95% CI 2.69, 20.03]), but no difference was observed in subsequent births.Conclusion: Pregnancy complications were more frequent in SLE patients than references, and the greatest differences between groups were observed in first births.
- 28 January 2014
- Published by Wiley in Acta Obstetricia et Gynecologica Scandinavica
- Vol. 93 (3) , 302-307
Rheumatoid arthritis and outcomes in first and subsequent births based on data from a national birth registry
Objective: To examine associations between rheumatoid arthritis (RA) and pregnancy outcomes in first and subsequent births.Design: Cohort study.Setting: Study based on data registered in the Medical Birth Registry of Norway from the period 1 December 1998 to 31 December 2009.Population: Singleton births in women recorded with RA (n = 1496) and reference deliveries from the general population (n = 625 642).Methods: Outcomes of first and subsequent births were analyzed separately. First birth was defined as the first delivery of nulliparous women. Associations between RA and maternal and perinatal outcomes were assessed in logistic regression analyses and adjusted for maternal age at delivery, gestational age, smoking habits and for previous cesarean section when relevant.Main outcome measures: Maternal and perinatal outcomes.Results: Vaginal bleeding was observed more often among women with RA both in first pregnancy [adjusted odds ratio (aOR) 1.8, 95% CI 1.3–2.4] and in subsequent pregnancies (aOR 1.4, 95% CI 1.1–1.9). Elective cesarean section was more common among women with RA both in the first birth (aOR 2.0, 95% CI 1.4–2.8) and in subsequent births (aOR 1.5, 95% CI 1.2–2.0). Preterm delivery was more frequent among women with RA than the reference population in first pregnancy (aOR 1.5, 95% CI 1.1–2.0) and in subsequent pregnancies (aOR 1.5, 95% CI 1.1–1.9).Conclusion: Complications and poor pregnancy outcomes were more often observed in women with RA and the greatest differences were observed in the first pregnancy.
- 28 January 2014
- Published by Wiley in Acta Obstetricia et Gynecologica Scandinavica
- Vol. 93 (3) , 302-307
Rheumatoid arthritis and outcomes in first and subsequent births based on data from a national birth registry
Objective: To examine associations between rheumatoid arthritis (RA) and pregnancy outcomes in first and subsequent births.Design: Cohort study.Setting: Study based on data registered in the Medical Birth Registry of Norway from the period 1 December 1998 to 31 December 2009.Population: Singleton births in women recorded with RA (n = 1496) and reference deliveries from the general population (n = 625 642).Methods: Outcomes of first and subsequent births were analyzed separately. First birth was defined as the first delivery of nulliparous women. Associations between RA and maternal and perinatal outcomes were assessed in logistic regression analyses and adjusted for maternal age at delivery, gestational age, smoking habits and for previous cesarean section when relevant.Main outcome measures: Maternal and perinatal outcomes.Results: Vaginal bleeding was observed more often among women with RA both in first pregnancy [adjusted odds ratio (aOR) 1.8, 95% CI 1.3–2.4] and in subsequent pregnancies (aOR 1.4, 95% CI 1.1–1.9). Elective cesarean section was more common among women with RA both in the first birth (aOR 2.0, 95% CI 1.4–2.8) and in subsequent births (aOR 1.5, 95% CI 1.2–2.0). Preterm delivery was more frequent among women with RA than the reference population in first pregnancy (aOR 1.5, 95% CI 1.1–2.0) and in subsequent pregnancies (aOR 1.5, 95% CI 1.1–1.9).Conclusion: Complications and poor pregnancy outcomes were more often observed in women with RA and the greatest differences were observed in the first pregnancy.
- Open Access
- 27 March 2012
- Published by Norwegian Medical Association in Tidsskrift for Den norske legeforening
- Vol. 132 (6) , 658-62
Kronisk inflammatorisk artritt og svangerskap
Chronic inflammatory arthritis often appears first in women of fertile age. Their pregnancies are considered to be of low risk compared with pregnancies in women with systemic inflammatory connective tissue disease. The article is based on literature searches in PubMed for studies of the pregnancy outcomes of women with chronic inflammatory arthritis. Studies without a reference group or studies based on analyses of mixed populations of inflammatory arthritis and connective tissue disease patients were excluded. Recurrent findings in the published literature were: low mean birth weight, a higher proportion of children with a birth weight of less than 2500 grams, children born small for gestational age, preterm births and a higher proportion of Caesarean sections. A high level of disease activity is associated with the risk of low birth weight and preterm birth. However, serious complications are not frequently reported. Glucocorticosteroids and disease-modifying medicines such as sulphasalazine and hydroxychloroquine may be used during pregnancy. Non-steroidal anti-inflammatory drugs such as ibuprofen and naproxen may be used until gestational week 32. Methotrexate is contraindicated and must be terminated three months before conception. The TNF inhibitors adalimumab, etanercept and infliximab may be used until conception. Pregnancy is seldom absolutely contraindicated for women with inflammatory arthritis. Pregnancy should be planned carefully and preferably be confined to periods with a low level of disease activity. First pregnancies require special attention. Interdisciplinary collaboration between rheumatologists and gynaecologists is recommended for monitoring patients with active arthritis.
- 27 March 2012
- Published by Norwegian Medical Association in Tidsskrift for Den norske legeforening
- Vol. 132 (6) , 658-62
Open AccessKronisk inflammatorisk artritt og svangerskap
Chronic inflammatory arthritis often appears first in women of fertile age. Their pregnancies are considered to be of low risk compared with pregnancies in women with systemic inflammatory connective tissue disease. The article is based on literature searches in PubMed for studies of the pregnancy outcomes of women with chronic inflammatory arthritis. Studies without a reference group or studies based on analyses of mixed populations of inflammatory arthritis and connective tissue disease patients were excluded. Recurrent findings in the published literature were: low mean birth weight, a higher proportion of children with a birth weight of less than 2500 grams, children born small for gestational age, preterm births and a higher proportion of Caesarean sections. A high level of disease activity is associated with the risk of low birth weight and preterm birth. However, serious complications are not frequently reported. Glucocorticosteroids and disease-modifying medicines such as sulphasalazine and hydroxychloroquine may be used during pregnancy. Non-steroidal anti-inflammatory drugs such as ibuprofen and naproxen may be used until gestational week 32. Methotrexate is contraindicated and must be terminated three months before conception. The TNF inhibitors adalimumab, etanercept and infliximab may be used until conception. Pregnancy is seldom absolutely contraindicated for women with inflammatory arthritis. Pregnancy should be planned carefully and preferably be confined to periods with a low level of disease activity. First pregnancies require special attention. Interdisciplinary collaboration between rheumatologists and gynaecologists is recommended for monitoring patients with active arthritis.
- 24 February 2012
- Published by Taylor & Francis in Scandinavian Journal of Rheumatology
- Vol. 41 (3) , 202-207
Parity in patients with chronic inflammatory arthritides childless at time of diagnosis
Objective: To assess parity in women with chronic inflammatory arthritides (CIA) childless at time of diagnosis. Methods: Patients were selected from the Norwegian Disease-Modifying Anti-Rheumatic Drug (NOR-DMARD) registry. Each patient was matched by year of birth with 100 reference women from the Norwegian Population Registry. Data linkage for patients and references with the Medical Birth Registry of Norway (MBRN) identified all offspring until time of linkage (October 2007). Patients and corresponding references childless at the time of diagnosis were included in the analyses. Kaplan–Meier curves visualized the proportion of childless women and were compared by a log rank test. Results: In all, 156 rheumatoid arthritis (RA), 107 other chronic arthritides (OCA), and 75 juvenile idiopathic arthritis (JIA) patients were childless at time of diagnosis. At the time of data linkage, the proportions (%) of childless RA/OCA/JIA patients versus references were 61.5/62.6/57.3 versus 46.9/42.9/41.0, respectively, all differences statistically significant. The log rank test showed lower parity in all diagnostic groups compared with references (p < 0.001 for RA and OCA and p = 0.002 for JIA). No difference in parity was observed between RA and OCA patients, but both diagnostic groups had lower parity than JIA patients (p = 0.001). Disease characteristics were similar between childless and fertile patients. Conclusions: Reduced parity was observed in all diagnostic groups compared with references. RA and OCA patients had lower parity than JIA patients, indicating that having the disease as a young adult may influence parity more than having the disease in childhood.
- 24 February 2012
- Published by Taylor & Francis in Scandinavian Journal of Rheumatology
- Vol. 41 (3) , 202-207
Parity in patients with chronic inflammatory arthritides childless at time of diagnosis
Objective: To assess parity in women with chronic inflammatory arthritides (CIA) childless at time of diagnosis. Methods: Patients were selected from the Norwegian Disease-Modifying Anti-Rheumatic Drug (NOR-DMARD) registry. Each patient was matched by year of birth with 100 reference women from the Norwegian Population Registry. Data linkage for patients and references with the Medical Birth Registry of Norway (MBRN) identified all offspring until time of linkage (October 2007). Patients and corresponding references childless at the time of diagnosis were included in the analyses. Kaplan–Meier curves visualized the proportion of childless women and were compared by a log rank test. Results: In all, 156 rheumatoid arthritis (RA), 107 other chronic arthritides (OCA), and 75 juvenile idiopathic arthritis (JIA) patients were childless at time of diagnosis. At the time of data linkage, the proportions (%) of childless RA/OCA/JIA patients versus references were 61.5/62.6/57.3 versus 46.9/42.9/41.0, respectively, all differences statistically significant. The log rank test showed lower parity in all diagnostic groups compared with references (p < 0.001 for RA and OCA and p = 0.002 for JIA). No difference in parity was observed between RA and OCA patients, but both diagnostic groups had lower parity than JIA patients (p = 0.001). Disease characteristics were similar between childless and fertile patients. Conclusions: Reduced parity was observed in all diagnostic groups compared with references. RA and OCA patients had lower parity than JIA patients, indicating that having the disease as a young adult may influence parity more than having the disease in childhood.
- Open Access
- 3 February 2011
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 50 (6) , 1162-1167
Fertility in women with chronic inflammatory arthritides
Objective. To compare fertility rates in women with RA, other chronic arthritides (OCAs) and JIA with reference women from the general population. Methods. Each woman from a Norwegian patient registry was matched by year of birth with 100 reference women randomly selected from the National Population Registry. Data linkage of patients and references with the Medical Birth Registry of Norway (MBRN) identified all offspring in patients and references until October 2007, and indirectly also nulliparous (childless) women. Groups were compared with Mann–Whitney U-test for continuous variables and chi-squared tests for categorical variables. Poisson regression analysis was applied to calculate relative fertility rates in the diagnostic groups vs references. Results. Among 631 patients 849 children were registered in MBRN. Of these, 289 children (34.0%) were born after time of diagnosis vs 44.3% in references. Altogether, 206 of 631 patients (32.6%) were nulliparous vs 26.4% in references (P < 0.001). Among RA patients, 28.4% (96 of 338) were nulliparous vs 24.5% in references (P = 0.09), 30.7% (67 of 218) in OCA patients vs 24.5% in references (P = 0.03) and 57.3% (43 of 75) in JIA patients vs 40.9% in references (P = 0.004). Adjusted relative fertility rates in RA, OCA and JIA after diagnosis were 0.88, 0.84 and 0.84, respectively, compared with references. Conclusion. A higher proportion of women with chronic inflammatory arthritides were nulliparous compared with references, and relative fertility rates were reduced in all patient groups.
- 3 February 2011
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 50 (6) , 1162-1167
Open AccessFertility in women with chronic inflammatory arthritides
Objective. To compare fertility rates in women with RA, other chronic arthritides (OCAs) and JIA with reference women from the general population. Methods. Each woman from a Norwegian patient registry was matched by year of birth with 100 reference women randomly selected from the National Population Registry. Data linkage of patients and references with the Medical Birth Registry of Norway (MBRN) identified all offspring in patients and references until October 2007, and indirectly also nulliparous (childless) women. Groups were compared with Mann–Whitney U-test for continuous variables and chi-squared tests for categorical variables. Poisson regression analysis was applied to calculate relative fertility rates in the diagnostic groups vs references. Results. Among 631 patients 849 children were registered in MBRN. Of these, 289 children (34.0%) were born after time of diagnosis vs 44.3% in references. Altogether, 206 of 631 patients (32.6%) were nulliparous vs 26.4% in references (P < 0.001). Among RA patients, 28.4% (96 of 338) were nulliparous vs 24.5% in references (P = 0.09), 30.7% (67 of 218) in OCA patients vs 24.5% in references (P = 0.03) and 57.3% (43 of 75) in JIA patients vs 40.9% in references (P = 0.004). Adjusted relative fertility rates in RA, OCA and JIA after diagnosis were 0.88, 0.84 and 0.84, respectively, compared with references. Conclusion. A higher proportion of women with chronic inflammatory arthritides were nulliparous compared with references, and relative fertility rates were reduced in all patient groups.